ATE94758T1 - Verwendung von gangliosiden zur behandlung der dysfunktion des autonomen nervensystems bei der chagas-krankheit. - Google Patents

Verwendung von gangliosiden zur behandlung der dysfunktion des autonomen nervensystems bei der chagas-krankheit.

Info

Publication number
ATE94758T1
ATE94758T1 AT89122904T AT89122904T ATE94758T1 AT E94758 T1 ATE94758 T1 AT E94758T1 AT 89122904 T AT89122904 T AT 89122904T AT 89122904 T AT89122904 T AT 89122904T AT E94758 T1 ATE94758 T1 AT E94758T1
Authority
AT
Austria
Prior art keywords
gangliosides
nervous system
treat
chagas disease
system dysfunction
Prior art date
Application number
AT89122904T
Other languages
English (en)
Inventor
Valle Francesco Della
Daniel J Iosa
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Application granted granted Critical
Publication of ATE94758T1 publication Critical patent/ATE94758T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT89122904T 1989-06-08 1989-12-12 Verwendung von gangliosiden zur behandlung der dysfunktion des autonomen nervensystems bei der chagas-krankheit. ATE94758T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8948063A IT1236584B (it) 1989-06-08 1989-06-08 Uso di gangliosidi nel trattamento della disfunzione autonomica nel morbo di chagas
EP89122904A EP0401426B1 (de) 1989-06-08 1989-12-12 Verwendung von Gangliosiden zur Behandlung der Dysfunktion des autonomen Nervensystems bei der Chagas-Krankheit

Publications (1)

Publication Number Publication Date
ATE94758T1 true ATE94758T1 (de) 1993-10-15

Family

ID=11264293

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89122904T ATE94758T1 (de) 1989-06-08 1989-12-12 Verwendung von gangliosiden zur behandlung der dysfunktion des autonomen nervensystems bei der chagas-krankheit.

Country Status (5)

Country Link
EP (1) EP0401426B1 (de)
AT (1) ATE94758T1 (de)
DE (1) DE68909399T2 (de)
ES (1) ES2058457T3 (de)
IT (1) IT1236584B (de)

Also Published As

Publication number Publication date
EP0401426A1 (de) 1990-12-12
DE68909399D1 (de) 1993-10-28
DE68909399T2 (de) 1994-03-24
IT1236584B (it) 1993-03-16
ES2058457T3 (es) 1994-11-01
EP0401426B1 (de) 1993-09-22
IT8948063A0 (it) 1989-06-08

Similar Documents

Publication Publication Date Title
DE59205846D1 (de) Azaheterocyclylmethyl-chromane als Wirkstoffe zur Behandlung von Erkrankungen des Zentralnervensystems
ATE184792T1 (de) 2-bromomelatonin zur behandlung von schlafstörungen
DE69031279D1 (de) Neurologische wirkstoffe zur nasalen verabreichung an das gehirn
DE59109222D1 (de) Verwendung des Wirkstoffs Flupirtin zur Herstellung eines Arzneimittels zur Bekämpfung von Muskelverspannungen
FI821598L (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1-alkyl-2-aminotetralinderivat
ES2194025T3 (es) Toxinas botulinicas multiples para tratar trastornos y enfermedades neuromusculares.
ATE411026T1 (de) Mittel zur behandlung der alzheimer-krankheit
ES2007411A6 (es) Procedimiento de preparar nuevos agentes psicoestimulantes.
DE3480053D1 (en) A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor
ATE82681T1 (de) 2',3'-dideoxy-3'-fluorothymidin und verwandte verbindungen zur behandlung von adenovirusinfektionen.
FR2555050B1 (fr) Compositions pharmaceutiques et procede de preparation de compositions de phosphatidylserine, utilisables au traitement de desordres du systeme nerveux central sans exercer d'effets sur la coagulation du sang
FR2585572B3 (fr) Nouvelles compositions pharmaceutiques a base d'un sel de l'acide p. chlorophenoxyacetique destinees au traitement des neuropathies et assurant la regeneration nerveuse
ATE94758T1 (de) Verwendung von gangliosiden zur behandlung der dysfunktion des autonomen nervensystems bei der chagas-krankheit.
PH24094A (en) 5-aryl-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
ZA874597B (en) The use of exogenous gangliosides in tumoral diseases as a protective factor against toxicity by antitumoral drugs
DE3775854D1 (de) Arzneimittel zur therapie von durch funktionelle und organische basen verursachten gehirnkrankheiten.
DE69327207D1 (de) Tryptamine zur Behandlung von Störungen der circadianen Rhythmik
FR2575158B1 (fr) Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
ES2081884T3 (es) Factor citotoxico oligodendrocitico.
DE3875065D1 (de) Verwendung von nalmefen zur herstellung eines arzneimittels zur behandlung der schaedigung des zentralnervensystems.
DK0608648T3 (da) Højdoserede vitamin A-præparater
DE69118847D1 (de) Verwendung von Heptastigmin zur Behandlung der zerebralen Ictus
DE3579642D1 (de) Zusammensetzung zur herstellung eines arzneimittels zur therapeutischen behandlung von hauttrauma.
ATE56360T1 (de) Zusammensetzung zur herstellung eines arzneimittels zur therapeutischen behandlung von hauttrauma.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee